Osel Devices Limited to Acquire 90.69% Stake in SFL Hearing Solutions Private Limited
Osel Devices Limited announced on March 24, 2026, that its subsidiary, Osel Healthcare Private Limited, has entered into a Share Purchase Agreement to acquire 90.69% of the equity share capital of SFL Hearing Solutions Private Limited. The transaction is subject to fulfilling the terms and conditions outlined in the agreement.Upon completion, SFL Hearing Solutions Private Limited will become a subsidiary of Osel Healthcare Private Limited and a step-down subsidiary of Osel Devices Limited. The consideration for the acquisition is an amount of Rs. 30 Crore.
The Share Purchase Agreement grants rights including board nomination rights, affirmative voting rights on reserved matters, pre-emptive rights, anti-dilution protection, and information/inspection rights in SFL Hearing Solutions Private Limited.
The transaction does not constitute a related party transaction and does not result in a direct change in control or management of Osel Devices Limited.
Osel Healthcare Private Limited and Osel Devices Limited did not hold any shareholding in SFL Hearing Solutions Private Limited prior to the execution of the Share Purchase Agreement. U&N Enterprises Private Limited is also a party to the agreement.
Table: Key Details of the Share Purchase Agreement
| Particulars | Details of Information |
|---|---|
| Purpose of Agreement | To record the acquisition of 90.69% of SFL Hearing Solutions Private Limited’s equity share capital. |
| Significant Terms | Includes board nomination rights, affirmative voting rights, pre-emptive rights, anti-dilution protection, and information/inspection rights. |
| Impact on Management/Control | No direct change in control or management of Osel Devices Limited. |
| Acquisition Cost | Rs. 30 Crore |
| Related Party Status | Not Applicable |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.